NasdaqGS:OMCLMedical Equipment
Omnicell (OMCL) Is Up 13.7% After Earnings Beat, Raised Guidance, And Key Pharmacy Hire - What's Changed
In late April 2026, Omnicell reported first-quarter revenue of US$309.88 million and net income of US$11.36 million, issued second-quarter and full-year 2026 revenue guidance, and added veteran hospital pharmacy leader Rick Couldry as Senior Vice President, Chief Pharmacy and Clinical Officer.
The combination of stronger profitability, higher full-year adjusted earnings guidance, and a new senior clinical voice on Omnicell’s product roadmap highlights how the company is trying to align its...